Geron Corp (GERN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GERN | PTGX | ACAD | ||
| Company | Geron Corp | Protagonist Therapeutics Inc | Acadia Pharmaceutica | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 4.08 | 46.30 | 14.73 | ||
| High | 4.26 | 47.76 | 15.02 | ||
| Low | 3.98 | 45.37 | 14.60 | ||
| Last | 4.25 | 46.76 | 14.62 | ||
| Change | +0.14 | unch | -0.19 | ||
| % Change | +3.41% | unch | -1.28% | ||
| Volume | 7,032,000 | 375,800 | 2,793,600 | ||
| 20-Day Average Volume | 6,933,220 | 458,920 | 1,133,405 | ||
| Previous Close | 4.11 | 46.76 | 14.81 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 4.15 | 46.43 | 14.73 | ||
| 20-Day Raw Stochastic | 75.81% | 62.70% | 33.33% | ||
| 20-Day Relative Strength | 49.81% | 55.29% | 43.86% | ||
| Weighted Alpha | +64.08 | +167.94 | -40.65 | ||
| Today's Opinion | 8% Buy | 96% Buy | 100% Sell | ||
| Previous Opinion | 24% Sell | 96% Buy | 88% Sell | ||
| Last Month's Opinion | 24% Buy | 88% Buy | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.71% since 10/28/24 | -2.99% since 10/28/24 | -0.81% since 10/28/24 | ||
| Low | 3.98 on 11/04/24 | 45.37 on 11/04/24 | 14.45 on 10/31/24 | ||
| High | 4.31 on 11/01/24 | 48.62 on 10/29/24 | 15.02 on 11/04/24 | ||
| 1-Month | |||||
| %Chg | -1.62% since 10/04/24 | +5.39% since 10/04/24 | -3.18% since 10/04/24 | ||
| Low | 3.87 on 10/22/24 | 42.78 on 10/07/24 | 14.15 on 10/23/24 | ||
| High | 4.37 on 10/10/24 | 48.89 on 10/28/24 | 15.56 on 10/21/24 | ||
| 3-Month | |||||
| %Chg | -7.00% since 08/02/24 | +25.16% since 08/02/24 | -22.11% since 08/02/24 | ||
| Low | 3.87 on 10/22/24 | 32.50 on 08/05/24 | 14.15 on 10/23/24 | ||
| High | 4.84 on 08/12/24 | 48.89 on 10/28/24 | 18.96 on 08/06/24 | ||
| 6-Month | |||||
| %Chg | +8.14% since 05/03/24 | +79.23% since 05/03/24 | -14.25% since 05/03/24 | ||
| Low | 3.23 on 05/30/24 | 25.23 on 05/07/24 | 14.15 on 10/23/24 | ||
| High | 5.34 on 06/12/24 | 48.89 on 10/28/24 | 19.44 on 07/31/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,477,492 | 2,754,397 | 2,456,624 | ||
| Shares Outstanding, K | 602,796 | 58,905 | 165,876 | ||
| Annual Sales | 240,000 | 60,000,000 | 726,440,000 | ||
| Annual Net Income | -184,130,000 | -78,960,000 | -61,290,000 | ||
| Last Quarter Sales | 880,000 | 4,170,000 | 241,960,000 | ||
| Last Quarter Net Income | -67,380,000 | -30,620,000 | 33,390,000 | ||
| 60-Month Beta | 0.52 | 2.17 | 0.38 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.10 on 08/08/24 | -0.50 on 08/06/24 | 0.20 on 08/06/24 | ||
| Latest Earnings Date | 11/07/24 | 11/07/24 | 11/06/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.50 | 81.06 | ||